Confidential Ongoing Pharmaceutical Mass Tort Matter
Analysis Group was retained by DLA Piper on behalf of the defendants in this mass tort case in which plaintiffs alleged that a branded drug caused adverse cardiovascular events, including death. The team, which included Managing Principal Pierre Cremieux
, Principal Almudena Arcelus
, and Vice Presidents Arindam Ghosh
and Nikita Piankov
, supported counsel and assessed plaintiffs’ claims of increased cardiovascular risks from use of the drug. The team supported a number of experts, including academic affiliate and Harvard School of Public Health Professor Lee-Jen Wei
, in conducting a meta-analysis of clinical trial data associated with the drug at issue.